OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine (vol 78, pg 589, 2018)

被引：2
|
作者：
Frampton, James E. [1 ]
Silberstein, Stephen [2 ]
机构：
[1] Springer, Private Bag 65901, Auckland 0754, New Zealand
[2] Jefferson Headache Ctr, Philadelphia, PA USA
来源：
DRUGS | 2018年 / 78卷 / 06期
关键词：
D O I：
10.1007/s40265-018-0906-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The article OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine, written by James E. Frampton and Stephen Silberstein, was originally published Online First without open access. After publication in volume 78, issue 5, pages 589–600 [funder] requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by [funder]. Further details may be found at [MedEngine webpage link].
引用
收藏
页码：715 / 715
页数：1
相关论文
共 50 条
  • [31] Recent Work on Pain (vol 78, pg 737, 2018)
    Corns, Jennifer
    ANALYSIS, 2020, 80 (01) : 202 - 202
  • [32] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Blumenfeld, Andrew M.
    Stark, Richard J.
    Freeman, Marshall C.
    Orejudos, Amelia
    Adams, Aubrey Manack
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [33] Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
    Andrew M. Blumenfeld
    Richard J. Stark
    Marshall C. Freeman
    Amelia Orejudos
    Aubrey Manack Adams
    The Journal of Headache and Pain, 2018, 19
  • [34] Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review (vol 13, pg 1571, 2024)
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Cook, Lisa
    Rhyne, Christopher
    Jenkins, Brian
    Hughes, Olivia
    Dabruzzo, Brett
    Manack Adams, Aubrey
    Diamond, Merle
    PAIN AND THERAPY, 2025, 14 (01) : 441 - 444
  • [35] FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
    Rothrock, John F.
    Adams, Aubrey Manack
    Lipton, Richard B.
    Silberstein, Stephen D.
    Jo, Esther
    Zhao, Xiang
    Blumenfeld, Andrew M.
    HEADACHE, 2019, 59 (10): : 1700 - 1713
  • [36] Erenumab and OnabotulinumtoxinA Combination Therapy for the Prevention of Intractable Chronic Migraine without Aura: A Retrospective Analysis
    Armanious, Mark
    Khalil, Nadia
    Lu, Yuanyuan
    Jimenez-Sanders, Rebecca
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2021, 35 (01) : 1 - 6
  • [37] Chronic hepatitis B infection: a review (vol 319, pg 1802, 2018)
    Tang, L. S. Y.
    Covert, E.
    Wilson, E.
    Kottilil, S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (11): : 1202 - 1202
  • [38] Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers (vol 78, pg 747, 2018)
    Scott, Lesley J.
    DRUGS, 2018, 78 (07) : 759 - 759
  • [39] Pharmacologic Prevention of Migraine: A Narrative Review of the State of the Art in 2018
    Loder, Elizabeth
    Rizzoli, Paul
    HEADACHE, 2018, 58 : 218 - 229
  • [40] Caplacizumab: First Global Approval (vol 78, pg 1638, 2018)
    Duggan, Sean
    DRUGS, 2018, 78 (18) : 1955 - 1955
12345